Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Kseniia Bielosludtseva (Dniepropetrovsk, Ukraine), Kseniia Bielosludtseva, Tetyana Pertseva, Tetyana Kireyeva. Can procalcitonin or C-reactive protein predict supporative lung complications and ARDS at severe community-acquired pneumonia (CAP)?. Eur Respir J 2016; 48: Suppl. 60, 600

Member's Comments

No comment yet.

Related content which might interest you: Helmet ventilation in AIDS patients with severe pneumonia and acute hypoxaemic respiratory failure Source: Annual Congress 2013 –NIV in the acute setting: growing experience and novel applications Year: 2013 Acute respiratory distress syndrome in patients admitted for community-acquired pneumonia Source: International Congress 2014 – ARDS, skeletal muscles, physiology and weaning Year: 2014 Clinical and microbiological characteristics and outcome of ARDS in India Source: International Congress 2016 – Dealing with the complexity of critically-ill patients Year: 2016 Procalcitonin as etiological marker of severe community-acquired pneumonia Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013 Radiologic features of lung involvement in young patients with viral pneumonia Source: International Congress 2016 – Mixed-up imaging of various chest diseases Year: 2016 Outcome of acute drug-induced pneumonias in ICU Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Methotrexate reduces acute lung injury in a murine model of sepsis Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism Year: 2016 Physiological score SIPF (shock index and hypoxemia) is an accurate predictor of ICU admission in community-acquired pneumonia Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014 Acute respiratory failure and severe sepsis may identify different clinical phenotypes in community-acquired pneumonia Source: Annual Congress 2013 –Interesting research questions Year: 2013 Markers of poor outcome in patients with acute hypoxemic respiratory failure Source: International Congress 2014 – ICU outcomes, sepsis and infections Year: 2014 Role of procalcitonin in predicting severity and in-hospital mortality in patients with community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 Procalcitonin (PCT) and C-reactive protein (CRP) as markers of the differential diagnosis of severe community acquired pneumonia (sCAP) Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment Year: 2013 Septic pulmonary embolisms as a cause of acute respiratory distress syndrome Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Morbi-mortality evaluation in prolonged prone positioning during severe ARDS Source: International Congress 2015 – Acute critical care: novelties in critical care Year: 2015 Prognostic value of procalcitonin in community-acquired pneumonia Source: Eur Respir J 2011; 37: 384 Year: 2011 Preoperative statin administration does not protect against early postoperative acute respiratory distress syndrome (ARDS): A retrospective cohort study Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations Year: 2013 Risk factors for mortality in severe pneumonia patients followed in ICU Source: International Congress 2015 – Acute critical care: novelties in critical care Year: 2015 Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients Source: International Congress 2016 – Sepsis and ARDS: looking forward Year: 2016 Drug-associated acute respiratory distress syndrome: A prospective observational cohort study Source: International Congress 2015 – IPF: clinical aspects II Year: 2015